An interventional study of Echopulse in Non-malignant Thyroid Nodules, sponsored by Theraclion. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-08-28.
Sponsored by Theraclion · Not applicable, Interventional, and Treatment
Use of a high intensity focused ultrasound (HIFU) in patients with non-malignant thyroid nodules.
Theraclion is the lead sponsor of 18 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patient presenting with at least one thyroid nodule with no signs of malignancy:
Exclusion Criteria:
Device: Echopulse
Evaluation of thyroid nodule's volume changes following HIFU therapy assessed by ultrasonography (US)
Time frame: Month 6 and Month 12
Evaluation of thyroid nodule's structure changes following HIFU therapy assessed by ultrasonography (US)
Time frame: Month 6 and Month 12
Evaluation of thyroid nodule's vascularisation changes following HIFU therapy assessed by ultrasonography (US)
Time frame: Month 6 and Month 12
Number of subjects with adverse events as a measure of safety and tolerability
Time frame: Day 1, Month 1, Month 3, Month 6 and Month 12
This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Theraclion